Cane Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.19M Sell
4,477
-401
-8% -$106K 0.44% 53
2026
Q2
$1.24M Buy
4,878
+1,256
+35% +$293K 0.49% 49
2026
Q1
$885K Sell
3,622
-3,065
-46% -$714K 0.39% 51
2025
Q4
$1.38M Hold
6,687
– – 0.54% 38

Other funds holding JNJ

Cane Capital Partners's JNJ Position: Q3 2026 in Review

Cane Capital Partners reduced its Johnson & Johnson (JNJ) stake by 8.2% in Q3 2026, selling an estimated $106K and leaving 4,477 shares worth $1.19M. The position accounts for 0.44% of the portfolio, ranked #53.

Cane Capital Partners first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.38M in Q4 2025. 4,737 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Cane Capital Partners held 4,477 shares of Johnson & Johnson worth $1.19M as of Q3 2026.
  • Cane Capital Partners sold 401 Johnson & Johnson shares in Q3 2026, an estimated $106K.
  • Johnson & Johnson made up 0.44% of Cane Capital Partners's portfolio in Q3 2026, its #53 holding.
  • Cane Capital Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • Cane Capital Partners's Johnson & Johnson position peaked at $1.38M in Q4 2025.
  • 4,737 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.